Haemonetics Aktie

Haemonetics FCF-margin

Fri likviditetsstrøm-margin for Haemonetics (HAE) pr. 20. aug. 2026 er 19,52 %. I foregående år var Fri likviditetsstrøm-margin 10,47 % — en ændring på 86,51 % (højere).

FCF-margin

19,52 %

YoY

86,51%

Senest opdateret:

Fri likviditetsstrøm-margin for Haemonetics er 2026 19,52 % . Fri likviditetsstrøm-margin for Haemonetics var 2025 10,47 % . Det falder dermed med 86,51% højere sammenlignet med året før.
Access this data via the Eulerpool API

Haemonetics Aktieanalyse

Hvad laver Haemonetics? Haemonetics Corp is a leading provider of blood processing and transfusion products. The company was founded in 1971 by Dr. Jack Latham to create a better solution for the storage and transfer of blood products. Since then, the company has become a major provider of products and services for the blood transfusion industry. Haemonetics' business model is focused on the development, manufacturing, and marketing of products and devices for blood transfusion. The company offers a wide range of products and services, including blood processing systems, blood collection and maintenance devices, software solutions, blood components, and related accessories. In recent years, Haemonetics has dedicated itself to diversifying its offerings. While still focusing on the blood transfusion industry, the company has also expanded into other areas, such as the treatment of patients with blood disorders and the development of devices for cell therapy. Haemonetics is divided into various business segments, including Blood Management Solutions, Diagnostic Solutions, and Haemonetics Software Solutions. The Blood Management Solutions segment includes a range of products, including blood collection and storage devices, centrifuges, and hematocrit systems. Diagnostic Solutions provides diagnostic tests for blood disorders, including tests for coagulation disorders and thrombophilia. Haemonetics Software Solutions offers software solutions for the blood transfusion industry, including systems for automated processing and storage of blood products, as well as systems for automatic inventory management. Haemonetics' products also include devices for freezing blood products and for processing blood components. These devices help ensure that blood products are stored at optimal temperatures and conditions to ensure their effectiveness and usability for the patient. Another important area of Haemonetics' business is the development of devices for cell therapy. The company works closely with research institutes and biotech companies to develop innovative technologies for cell therapy. This includes the development of devices for the isolation and purification of stem cells that can be used for the treatment of cancer and other diseases. Haemonetics Corp has made a name for itself in the blood transfusion industry and continues to focus on innovation and diversification to fully utilize the potential of the company and its products. With a wide range of products and services, a strong commitment to research and development, and an unwavering focus on the needs of patients and healthcare providers, Haemonetics is well positioned to continue growing and expanding in the future. Haemonetics er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Haemonetics aktie

Fri likviditetsstrøm-margin for Haemonetics er 19,52 % i 2026.

Fri likviditetsstrøm-margin for Haemonetics ændrede sig fra 10,47 % til 19,52 %, hvilket repræsenterer en ændring på 86,51 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af Fri likviditetsstrøm-margin Haemonetics siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

FCF-marginen måler procentdelen af omsætningen, der konverteres til fri likviditetsstrøm. Den indikerer, hvor effektivt en virksomhed genererer kontanter fra sin drift.

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne Fri likviditetsstrøm-margins Haemonetics med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

For at evaluere Fri likviditetsstrøm-margins er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for Fri likviditetsstrøm-margin.

Access this data via the Eulerpool API

Marginer — Haemonetics

Alle nøgletal — Haemonetics